Результати пошуку - Ian Chau

Уточнити результати
  1. 1
    Treatment in advanced colorectal cancer: what, when and how?

    Treatment in advanced colorectal cancer: what, when and how? за авторством Ian Chau, David Cunningham

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Updates on Systemic Therapy for Hepatocellular Carcinoma

    Updates on Systemic Therapy for Hepatocellular Carcinoma за авторством Panagiotis Ntellas, Ian Chau

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer

    Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer за авторством Byung Woog Kang, Ian Chau

    Опубліковано 2020
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  4. 4
    Molecular target: pan-AKT in gastric cancer

    Molecular target: pan-AKT in gastric cancer за авторством Byung Woog Kang, Ian Chau

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer

    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer за авторством Milind Javle, Elizabeth Smyth, Ian Chau

    Опубліковано 2014
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  6. 6
    Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone?

    Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? за авторством Khurum Khan, Anita Wale, Gina Brown, Ian Chau

    Опубліковано 2014
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  7. 7
    Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer

    Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer за авторством Manish Chand, R I Swift, Paris Tekkis, Ian Chau, Gina Brown

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases

    Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases за авторством Dow‐Mu Koh, David J. Collins, Toni Wallace, Ian Chau, Angela M. Riddell

    Опубліковано 2012
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data

    Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Indiv... за авторством Ian Chau, Andy Norman, David Cunningham, Justin S. Waters, Jacqui Oates, Paul J. Ross

    Опубліковано 2004
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial

    Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 tria... за авторством Alicia Okines, Olivia del Puerto, David Cunningham, Ian Chau, Eric Van Cutsem, Leonard B. Saltz, J Cassidy

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

    Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey за авторством Sing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, David Cunningham, Ian Chau, Naureen Starling, David Watkins, Sheela Rao

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials

    Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials за авторством Jingya Yang, Yuxiao Li, Chi Ian Chau, Junnan Shi, Xianwen Chen, Hao Hu, Carolina Oi Lam Ung

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  13. 13
    Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

    Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/... за авторством Alicia Okines, S. Ashley, David Cunningham, J. Oates, Andrea Turner, Janine Webb, Claire Saffery, Yu Jo Chua, Ian Chau

    Опубліковано 2010
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

    Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial за авторством Thomas Gruenberger, John Bridgewater, Ian Chau, Pilar Alfonso, Michel Rivoire, Satvinder Mudan, S. Lasserre, Matthias Hermann, Daniel Waterkamp, René Adam

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience

    Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience за авторством Hendrik‐Tobias Arkenau, Geoff Chong, David Cunningham, David Watkins, Bhawna Sirohi, Ian Chau, Andrew Wotherspoon, A. Norman, Alan Horwich, Estella Matutes

    Опубліковано 2007
    Отримати повний текст Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:
  16. 16
    The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials

    The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four... за авторством Ian Chau, A. Norman, David Cunningham, J. Oates, Robert D. Hawkins, Timothy Iveson, M. Nicolson, Peter Harper, Michel Seymour, Tamas Hickish

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  17. 17
    Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer

    Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic can... за авторством J.C. Bendell, Eileen M. O’Reilly, Mark R. Middleton, Ian Chau, Howard S. Höchster, Anitra Fielding, Wendy Burke, Howard A. Burris

    Опубліковано 2015
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  18. 18
    Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience

    Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience за авторством Khurum Khan, Clare Peckitt, Francesco Sclafani, David Watkins, Sheela Rao, Naureen Starling, Vikram Jain, Sachin Trivedi, Susannah Stanway, David Cunningham, Ian Chau

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  19. 19
    MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer

    MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer за авторством Amy Lord, Nigel D’Souza, Annabel Shaw, Zena Rokan, Brendan Moran, Muti Abulafi, Shahnawaz Rasheed, Anuradha Chandramohan, Alison Corr, Ian Chau, Gina Brown

    Опубліковано 2020
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  20. 20
    Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

    Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer за авторством Ian Chau, Gina Brown, David Cunningham, Diana Tait, Andrew Wotherspoon, A. Norman, Niall C. Tebbutt, Mark Hill, Paul J. Ross, Alison Massey, J. Oates

    Опубліковано 2006
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: